8.20
Kamada Ltd stock is traded at $8.20, with a volume of 110.37K.
It is up +0.00% in the last 24 hours and down -10.87% over the past month.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
See More
Previous Close:
$8.20
Open:
$8.14
24h Volume:
110.37K
Relative Volume:
1.43
Market Cap:
$473.03M
Revenue:
$180.46M
Net Income/Loss:
$20.20M
P/E Ratio:
23.64
EPS:
0.3468
Net Cash Flow:
$16.59M
1W Performance:
-7.76%
1M Performance:
-10.87%
6M Performance:
+19.01%
1Y Performance:
+15.49%
Kamada Ltd Stock (KMDA) Company Profile
Compare KMDA vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
KMDA
Kamada Ltd
|
8.20 | 473.03M | 180.46M | 20.20M | 16.59M | 0.3468 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.04 | 56.99B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
115.93 | 48.94B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
9.70 | 43.30B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.14 | 33.94B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
531.82 | 23.31B | 3.18B | 1.33B | 1.04B | 27.90 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-21-25 | Initiated | The Benchmark Company | Buy |
| Jul-03-24 | Initiated | Stifel | Buy |
| Feb-02-18 | Initiated | Chardan Capital Markets | Buy |
Kamada Ltd Stock (KMDA) Latest News
Kamada shares drop as company halts Phase 3 study of inhaled AAT therapy - MSN
KMDA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Kamada (KMDA) director and 10% owner details 22M shares and options - Stock Titan
Analyst Downgrade: Can Kamada Ltd benefit from deglobalizationTrade Analysis Summary & High Win Rate Trade Alerts - baoquankhu1.vn
Kamada Shifts $14.4 Million Dividend Payment Date to April 7, 2026 - TipRanks
Kamada (NASDAQ: KMDA) moves $0.25 dividend payment to April 7, 2026 - Stock Titan
Kamada (KMDA) director Lilach Payorski reports options over 30,000 shares - Stock Titan
Benjamin Dekel Net Worth (2026) - GuruFocus
David Tsur Net Worth (2026) - GuruFocus
Amir London Net Worth (2026) - GuruFocus
Kamada Ltd Stock (ISIN: IL0010952647) Faces Headwinds Amid Plasma Supply Challenges - AD HOC NEWS
Kamada Ltd. (NASDAQ:KMDA) Short Interest Down 17.8% in February - MarketBeat
Kamada director reports option holdings on Form 3 | KMDA SEC FilingForm 3 - Stock Titan
Leon Recanati controls 6.04% of Kamada (NASDAQ: KMDA) in amended 13G/A - Stock Titan
Kamada (KMDA) VP Boris Gorelik details structured stock option grants - Stock Titan
Kamada (KMDA) CEO Amir London details shares and option grants - Stock Titan
Kamada (KMDA) VP Regulatory Affairs reports initial shares and option grants - Stock Titan
Kamada (KMDA) VP Shavit reports ordinary shares and option grants - Stock Titan
Kamada (NASDAQ: KMDA) VP reports initial share and option holdings - Stock Titan
Director David Tsur details Kamada (KMDA) share and option stakes - Stock Titan
Kamada (KMDA) VP Nir Eran discloses initial share and option holdings - Stock Titan
Kamada (KMDA) VP Quality details ordinary share and option holdings - Stock Titan
Kamada (KMDA) VP Human Resources reports direct stock option holdings - Stock Titan
Kamada (KMDA) director files Form 3 detailing multiple option grants - Stock Titan
Kamada (KMDA) CFO reports holdings of Ordinary Shares and options - Stock Titan
Leon Recanati details Kamada (KMDA) share and option stakes - Stock Titan
Kamada (KMDA) VP Jon Knight details multiple stock option holdings - Stock Titan
Kamada (KMDA) director discloses multiple stock option grants - Stock Titan
HC Wainwright Predicts Kamada's Q1 Earnings (NASDAQ:KMDA) - MarketBeat
HC Wainwright Predicts Kamada’s Q1 Earnings (NASDAQ:KMDA) - Defense World
Kamada (NASDAQ:KMDA) Downgraded by Wall Street Zen to “Buy” - Defense World
Kamada shares climb after upbeat 2026 outlook points to double-digit growth - MSN
Kamada (KMDA) VP General Counsel discloses option grants on Form 3 - Stock Titan
Benchmark Maintains Buy on Kamada Ltd. (KMDA) March 2026 - Meyka
Kamada's Pipeline And Biosimilars Set Stage For Future Earnings Expansion - Seeking Alpha
Sidoti Weighs in on Kamada’s Q1 Earnings (NASDAQ:KMDA) - Defense World
Benchmark reiterates Kamada stock Buy rating on solid results - Investing.com
KMDA SEC FilingsKamada Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Kamada Ltd. (NASDAQ:KMDA) to Issue $0.25 Annual Dividend - MarketBeat
Stifel reiterates Buy rating on Kamada stock, $11 price target By Investing.com - Investing.com Australia
Kamada Ltd’s Dependence on Investigator-Initiated Trials Poses Data Integrity and IP Risks to Its Long-Term Growth - TipRanks
Kamada declares $0.25 per share dividend, totaling $14.4 million By Investing.com - Investing.com Canada
Kamada Ltd (KMDA) Q4 2025 Earnings Call Highlights: Strong Reven - GuruFocus
Kamada declares $0.25 per share dividend, totaling $14.4 million - Investing.com Australia
Stifel reiterates Buy rating on Kamada stock, $11 price target - Investing.com
Kamada: Fourth Quarter Financial Results Overview - Bitget
Earnings call transcript: Kamada Ltd. Q4 2025 misses EPS forecast, stock drops - Investing.com Nigeria
Earnings call transcript: Kamada Ltd. Q4 2025 misses EPS forecast, stock drops By Investing.com - Investing.com South Africa
Kamada (KMDA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Kamada (KMDA) Q4 Results Fall Short of Forecasts for Earnings and Revenue - Bitget
Kamada Declares Cash Dividend of $0.25 Per Share, to be Paid in Accordance with an Adopted Annual Cash Dividend Policy - Bitget
Kamada Ltd Stock (KMDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):